For Immediate Release
Tanner Pharma Group
CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several healthcare conferences throughout the upcoming month of April. The team will join other global executives for the following events:
Pharmagora | April 7th – 8th | Paris, France
PQMD Global Health Policy Forum | April 11th – 12th | Washington, D.C.
CPhI North America | April 24th – 26th | Philadelphia, PA
US GCSG Conference | April 29th – May 2nd | Atlanta, GA
Asembia’s Specialty Pharmacy Summit | April 29th – May 2nd | Las Vegas, NV.
Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant supply chain. The company provides services through four synergistic divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerLAC, licensing, acquisition and commercialization; TannerGAP, global access programs; and TannerMAP, managed access programs.
Tanner Pharma representatives will include Richard Lambie, Global Director for TannerCTS, Jonathan Bracey, Managing Director UK – SVP of Corporate Development, and Rob Keel, Director for TannerMAP.
Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
Diana Mendoza | email@example.com | +1 704 552 8408
About Tanner Pharma Group
For over 16 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. By partnering with Tanner Pharma, biotech and pharma companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.
Tanner Pharma believes that access to medicines should have no borders and measures its value as a company based on the lives it helps to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus.
Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.